NKCFO LLC’s Elanco Animal Health ELAN Stock Holding History

NKCFO LLC’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,740	Closed	-$89K	–	103
2026 Q1	$89K	Hold	3,740	–	–	0.03%	93
2025 Q4	$85K	Hold	3,740	–	–	0.02%	81
2025 Q3	$75K	Buy	+3,740	New	+$62.7K	0.02%	94

Other funds holding ELAN

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

NKCFO LLC's ELAN Position: Q2 2026 in Review

NKCFO LLC sold out of Elanco Animal Health (ELAN) in Q2 2026, closing a stake of 3,740 shares — an estimated $89K sold.

NKCFO LLC first reported a position in ELAN in Q3 2025 and held it in 3 quarters. The position peaked at $89K in Q1 2026. 522 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

NKCFO LLC reported no remaining Elanco Animal Health position as of Q2 2026 after selling out during the quarter.
NKCFO LLC sold 3,740 Elanco Animal Health shares in Q2 2026, an estimated $89K.
NKCFO LLC first reported a position in Elanco Animal Health in Q3 2025 and held it in 3 quarters.
NKCFO LLC's Elanco Animal Health position peaked at $89K in Q1 2026.
522 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on NKCFO LLC's 13F filing for Q2 2026, filed 13 Aug 2026.